India plasma fractionation market size reached US$ 357.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 534.4 Million by 2032, exhibiting a growth rate (CAGR) of 4.50% during 2024-2032. The growing healthcare awareness among individuals is propelling the need for plasma-derived products, which is primarily driving the market growth across the country.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032 |
Historical Years
|
2018-2023
|
Market Size in 2023 | US$ 357.7 Million |
Market Forecast in 2032 | US$ 534.4 Million |
Market Growth Rate (2024-2032) | 4.50% |
Plasma fractionation is the downstream processing of donated plasma to create essential therapies and medicinal products. This involves the separation of plasma into distinct proteins or fractions through mechanical methods like centrifugation, depth filtration, precipitation, and chromatography. In contemporary fractionation processes, various techniques such as the manipulation of alcohol concentrations, duration, temperature, and pH are employed to extract specific therapeutic proteins. The advancement in technology complexity and the incorporation of in-process viral reduction treatments over the years have led to the emergence of novel protein therapeutics and enhancements in the purity and quality of the final products.
The plasma fractionation market in India has seen notable growth, aligning with the increasing demand for life-saving therapeutic products derived from plasma. Additionally, mechanical separation methods, including centrifugation, depth filtration, precipitation, and chromatography, form the basis of plasma fractionation in India. Besides this, modern fractionation processes in the country have evolved, incorporating advanced techniques, such as the manipulation of alcohol concentrations, duration, temperature, and pH to extract targeted therapeutic proteins. These advancements contribute to the production of high-quality and effective plasma-derived therapies. The complexity of technology in plasma fractionation has increased over the years in India, leading to the development of new protein therapeutics, which is acting as another significant growth-inducing factor. Moreover, the introduction of in-process viral reduction treatments has significantly improved the purity and safety of the final products. This is particularly crucial in the context of ensuring the safety of therapeutic proteins derived from plasma. Furthermore, the India plasma fractionation market finds application in various therapeutic areas, including immunology, hematology, neurology, and critical care medicine. Additionally, advancements in technology and quality control measures will likely contribute to the continued expansion of the plasma fractionation market in India, thereby ensuring a stable supply of essential therapeutic proteins to meet the healthcare needs of the population.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, sector, application, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product This Includes immunoglobulins, albumin, coagulation factor VIII, and coagulation factor IX.
Sector Insights:
A detailed breakup and analysis of the market based on the sector have also been provided in the report. This includes private sector and public sector.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes neurology, immunology, hematology, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, clinical research laboratories, and academic institutes.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Immunoglobulins, Albumin, Coagulation Factor VIII, Coagulation Factor IX |
Sectors Covered | Private Sector, Public Sector |
Applications Covered | Neurology, Immunology, Hematology, Others |
End Users Covered | Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes |
Regions Covered | North India, West and Central India, South India, East and Northeast India |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 2699 Five User License: US$ 3699 Corporate License: US$ 4699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |